Case Report on Laron Syndrome and Hypothyroidism
Author Information
Author(s): Cotta Oana R, Santarpia Libero, Curtò Lorenzo, Aimaretti Gianluca, Corneli Ginevra, Trimarchi Francesco, Cannavò Salvatore
Primary Institution: Department of Medicine and Pharmacology, University of Messina, Messina, Italy
Hypothesis
Is there a link between primary growth hormone insensitivity (Laron syndrome) and the development of hypothyroidism?
Conclusion
The study highlights that patients with Laron syndrome may develop hypothyroidism during treatment with recombinant insulin-like growth factor 1.
Supporting Evidence
- The patient was diagnosed with Laron syndrome due to a specific genetic mutation.
- Recombinant growth hormone treatment did not improve her growth velocity.
- The patient developed central hypothyroidism during treatment with recombinant insulin-like growth factor 1.
Takeaway
This study is about a girl with a growth problem who didn't grow taller even after treatment, and she also developed a thyroid issue.
Methodology
The case study involved genetic analysis, hormone level testing, and treatment with recombinant insulin-like growth factor 1.
Limitations
The findings are based on a single case, limiting generalizability.
Participant Demographics
A 15-year-old Caucasian girl from a Sicilian family.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website